We are live on ! Find out more
AVNR

AVANIR PHARMACEUTICALS, INC CL A
AVNR

Delisted

AVNR was delisted on the 12th of January, 2015.

Back to rankings

101 hedge funds and large institutions have $350M invested in AVANIR PHARMACEUTICALS, INC CL A in 2013 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 37 increasing their positions, 34 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

211% more call options, than puts

Call options by funds: $15.7M | Put options by funds: $5.04M

9% more repeat investments, than reductions

Existing positions increased: 37 | Existing positions reduced: 34

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

6% less funds holding

Funds holding: 108 → 101 (-7)

22% less capital invested

Capital invested by funds: $449M → $350M (-$99.4M)

30% less first-time investments, than exits

New positions opened: 16 | Existing positions closed: 23

Holders
101
Holders Change
-7
Holders Change %
-6.48%
% of All Funds
2.93%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
16
Increased
37
Reduced
34
Closed
23
Calls
$15.7M
Puts
$5.04M
Net Calls
+$10.6M
Net Calls Change
+$12.7M

Top Buyers

Rank Fund Capital Flow
1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$14.1M
2
State Street
State Street
Massachusetts
+$13.4M
3
Millennium Management
Millennium Management
New York
+$9.17M
4
BBA
Baker Bros. Advisors
New York
+$4.13M
5
Goldman Sachs
Goldman Sachs
New York
+$4.01M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$13.1M
2
BI
BVF Inc
California
-$10.3M
3
O
OrbiMed
New York
-$7.88M
4
Wellington Management Group
Wellington Management Group
Massachusetts
-$7.22M
5
AG
Artal Group
Luxembourg
-$4.54M
Name Holding Trade Value Shares
Change 		Change in
Stake
BA
51
BlackRock Advisors
Delaware
$333K +$38.7K +9,375 +10%
AIG
52
American International Group
New York
$330K -$6.06K -1,467 -1%
VOYA Investment Management
53
VOYA Investment Management
Georgia
$323K – – –
Wells Fargo
54
Wells Fargo
California
$275K +$237K +57,502 +238%
DekaBank Deutsche Girozentrale
55
DekaBank Deutsche Girozentrale
Germany
$273K +$8.26K +2,000 +2%
AC
56
Ascend Capital
California
$252K -$3.74M -904,370 -92%
ProShare Advisors
57
ProShare Advisors
Maryland
$251K -$281K -68,101 -48%
Principal Financial Group
58
Principal Financial Group
Iowa
$248K +$14.8K +3,595 +5%
Commonwealth Equity Services
59
Commonwealth Equity Services
Massachusetts
$243K +$14.4K +3,489 +5%
CL
60
Croft-Leominster
Maryland
$236K – – –
PP
61
PDT Partners
New York
$220K +$54.1K +13,100 +25%
Citigroup
62
Citigroup
New York
$215K +$94.1K +22,782 +55%
Bank of America
63
Bank of America
North Carolina
$212K -$49.3K -11,932 -16%
HSBC Holdings
64
HSBC Holdings
United Kingdom
$202K – – –
FAM
65
Fortaleza Asset Management
Illinois
$180K -$177K -42,975 -45%
UBS AM
66
UBS AM
Illinois
$176K +$39.6K +9,600 +22%
U
67
UBS
Switzerland
$154K -$710K -171,968 -79%
PPA
68
Parametric Portfolio Associates
Washington
$145K +$1.71K +415 +1%
GCP
69
GSA Capital Partners
United Kingdom
$123K +$151K +36,546 New
HI
70
HBK Investments
Texas
$105K +$129K +31,283 New
WMSA
71
Weiss Multi-Strategy Advisers
New York
$101K -$2.11M -510,000 -94%
LWM
72
Lyons Wealth Management
Florida
$86K – – –
T
73
TradeWorx
New Jersey
$86K +$105K +25,468 New
SCA
74
SAC Capital Advisors
Connecticut
$74K +$31.2K +7,561 +52%
VKH
75
Virtu KCG Holdings
New York
$73K -$50.6K -12,260 -36%
1 2
3
4 5

AVNR Hedge Fund Activity: Q4 2013 in Review

101 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in AVANIR PHARMACEUTICALS, INC CL A (AVNR) for Q4 2013, worth a combined $350M — down 22% from $449M a quarter earlier.

Sellers outnumbered buyers: 23 funds closed out of AVNR and 16 opened new positions — a net loss of 7 holders — while 34 trimmed existing stakes and 37 added.

The largest buyer was T. Rowe Price Associates, adding an estimated $14.1M. The largest seller was Fidelity Investments, cutting an estimated $13.1M.

  • 101 institutional investors held AVANIR PHARMACEUTICALS, INC CL A (AVNR) as of Q4 2013, down from 108 in Q3 2013.
  • Funds reported $350M of AVANIR PHARMACEUTICALS, INC CL A stock for Q4 2013, down 22% quarter-over-quarter.
  • 16 funds opened new AVANIR PHARMACEUTICALS, INC CL A positions in Q4 2013 and 23 closed out, a net change of -7 holders.
  • The largest AVANIR PHARMACEUTICALS, INC CL A buyer in Q4 2013 was T. Rowe Price Associates, an estimated $14.1M added.
  • The largest AVANIR PHARMACEUTICALS, INC CL A seller in Q4 2013 was Fidelity Investments, an estimated $13.1M sold.

Based on aggregated 13F filings for Q4 2013.